This report contains market size and forecasts of Human Insulin Drugs in global, including the following market information:
- Global Human Insulin Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
- Global Human Insulin Drugs Market Sales, 2018-2023, 2023-2030, (K Units)
- Global top five Human Insulin Drugs companies in 2022 (%)
The global Human Insulin Drugs market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Basal or Long-acting Insulins Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Human Insulin Drugs include Novo Nordisk, Sanofi, Eli Lilly, Biocon, Pfizer, Wockhardt, Julphar, Exir and Sedico. etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Insulin Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Insulin Drugs Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Human Insulin Drugs Market Segment Percentages, by Type, 2022 (%)
- Basal or Long-acting Insulins
- Bolus or Fast-acting Insulins
- Traditional Human Insulins
- Combination Insulins
- Biosimilar Insulins
Global Human Insulin Drugs Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Human Insulin Drugs Market Segment Percentages, by Application, 2022 (%)
Global Human Insulin Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Human Insulin Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Human Insulin Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Human Insulin Drugs revenues share in global market, 2022 (%)
- Key companies Human Insulin Drugs sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Human Insulin Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novo Nordisk
- Sanofi
- Eli Lilly
- Biocon
- Pfizer
- Wockhardt
- Julphar
- Exir
- Sedico
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Human Insulin Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Insulin Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Insulin Drugs Overall Market Size
2.1 Global Human Insulin Drugs Market Size: 2022 VS 2030
2.2 Global Human Insulin Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Human Insulin Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Human Insulin Drugs Players in Global Market
3.2 Top Global Human Insulin Drugs Companies Ranked by Revenue
3.3 Global Human Insulin Drugs Revenue by Companies
3.4 Global Human Insulin Drugs Sales by Companies
3.5 Global Human Insulin Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Insulin Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Insulin Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Insulin Drugs Players in Global Market
3.8.1 List of Global Tier 1 Human Insulin Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Insulin Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Insulin Drugs Market Size Markets, 2022 & 2030
4.1.2 Basal or Long-acting Insulins
4.1.3 Bolus or Fast-acting Insulins
4.1.4 Traditional Human Insulins
4.1.5 Combination Insulins
4.1.6 Biosimilar Insulins
4.2 By Type - Global Human Insulin Drugs Revenue & Forecasts
4.2.1 By Type - Global Human Insulin Drugs Revenue, 2018-2023
4.2.2 By Type - Global Human Insulin Drugs Revenue, 2023-2030
4.2.3 By Type - Global Human Insulin Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Human Insulin Drugs Sales & Forecasts
4.3.1 By Type - Global Human Insulin Drugs Sales, 2018-2023
4.3.2 By Type - Global Human Insulin Drugs Sales, 2023-2030
4.3.3 By Type - Global Human Insulin Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Human Insulin Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Human Insulin Drugs Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Household
5.2 By Application - Global Human Insulin Drugs Revenue & Forecasts
5.2.1 By Application - Global Human Insulin Drugs Revenue, 2018-2023
5.2.2 By Application - Global Human Insulin Drugs Revenue, 2023-2030
5.2.3 By Application - Global Human Insulin Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Human Insulin Drugs Sales & Forecasts
5.3.1 By Application - Global Human Insulin Drugs Sales, 2018-2023
5.3.2 By Application - Global Human Insulin Drugs Sales, 2023-2030
5.3.3 By Application - Global Human Insulin Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Human Insulin Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Human Insulin Drugs Market Size, 2022 & 2030
6.2 By Region - Global Human Insulin Drugs Revenue & Forecasts
6.2.1 By Region - Global Human Insulin Drugs Revenue, 2018-2023
6.2.2 By Region - Global Human Insulin Drugs Revenue, 2023-2030
6.2.3 By Region - Global Human Insulin Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Human Insulin Drugs Sales & Forecasts
6.3.1 By Region - Global Human Insulin Drugs Sales, 2018-2023
6.3.2 By Region - Global Human Insulin Drugs Sales, 2023-2030
6.3.3 By Region - Global Human Insulin Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Human Insulin Drugs Revenue, 2018-2030
6.4.2 By Country - North America Human Insulin Drugs Sales, 2018-2030
6.4.3 US Human Insulin Drugs Market Size, 2018-2030
6.4.4 Canada Human Insulin Drugs Market Size, 2018-2030
6.4.5 Mexico Human Insulin Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Human Insulin Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Human Insulin Drugs Sales, 2018-2030
6.5.3 Germany Human Insulin Drugs Market Size, 2018-2030
6.5.4 France Human Insulin Drugs Market Size, 2018-2030
6.5.5 U.K. Human Insulin Drugs Market Size, 2018-2030
6.5.6 Italy Human Insulin Drugs Market Size, 2018-2030
6.5.7 Russia Human Insulin Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Human Insulin Drugs Market Size, 2018-2030
6.5.9 Benelux Human Insulin Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Human Insulin Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Human Insulin Drugs Sales, 2018-2030
6.6.3 China Human Insulin Drugs Market Size, 2018-2030
6.6.4 Japan Human Insulin Drugs Market Size, 2018-2030
6.6.5 South Korea Human Insulin Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Human Insulin Drugs Market Size, 2018-2030
6.6.7 India Human Insulin Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Human Insulin Drugs Revenue, 2018-2030
6.7.2 By Country - South America Human Insulin Drugs Sales, 2018-2030
6.7.3 Brazil Human Insulin Drugs Market Size, 2018-2030
6.7.4 Argentina Human Insulin Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Insulin Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Human Insulin Drugs Sales, 2018-2030
6.8.3 Turkey Human Insulin Drugs Market Size, 2018-2030
6.8.4 Israel Human Insulin Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Human Insulin Drugs Market Size, 2018-2030
6.8.6 UAE Human Insulin Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Corporate Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Human Insulin Drugs Major Product Offerings
7.1.4 Novo Nordisk Human Insulin Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Novo Nordisk Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Human Insulin Drugs Major Product Offerings
7.2.4 Sanofi Human Insulin Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Key News
7.3 Eli Lilly
7.3.1 Eli Lilly Corporate Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Human Insulin Drugs Major Product Offerings
7.3.4 Eli Lilly Human Insulin Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Eli Lilly Key News
7.4 Biocon
7.4.1 Biocon Corporate Summary
7.4.2 Biocon Business Overview
7.4.3 Biocon Human Insulin Drugs Major Product Offerings
7.4.4 Biocon Human Insulin Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Biocon Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Human Insulin Drugs Major Product Offerings
7.5.4 Pfizer Human Insulin Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Pfizer Key News
7.6 Wockhardt
7.6.1 Wockhardt Corporate Summary
7.6.2 Wockhardt Business Overview
7.6.3 Wockhardt Human Insulin Drugs Major Product Offerings
7.6.4 Wockhardt Human Insulin Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Wockhardt Key News
7.7 Julphar
7.7.1 Julphar Corporate Summary
7.7.2 Julphar Business Overview
7.7.3 Julphar Human Insulin Drugs Major Product Offerings
7.7.4 Julphar Human Insulin Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Julphar Key News
7.8 Exir
7.8.1 Exir Corporate Summary
7.8.2 Exir Business Overview
7.8.3 Exir Human Insulin Drugs Major Product Offerings
7.8.4 Exir Human Insulin Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Exir Key News
7.9 Sedico
7.9.1 Sedico Corporate Summary
7.9.2 Sedico Business Overview
7.9.3 Sedico Human Insulin Drugs Major Product Offerings
7.9.4 Sedico Human Insulin Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Sedico Key News
8 Global Human Insulin Drugs Production Capacity, Analysis
8.1 Global Human Insulin Drugs Production Capacity, 2018-2030
8.2 Human Insulin Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Insulin Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Insulin Drugs Supply Chain Analysis
10.1 Human Insulin Drugs Industry Value Chain
10.2 Human Insulin Drugs Upstream Market
10.3 Human Insulin Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Insulin Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Human Insulin Drugs in Global Market
Table 2. Top Human Insulin Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Human Insulin Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Human Insulin Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Human Insulin Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Human Insulin Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Human Insulin Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Human Insulin Drugs Product Type
Table 9. List of Global Tier 1 Human Insulin Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Insulin Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Human Insulin Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Human Insulin Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Human Insulin Drugs Revenue (US$, Mn), 2023-2030
Table 14. By Type - Global Human Insulin Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Human Insulin Drugs Sales (K Units), 2023-2030
Table 16. By Application ? Global Human Insulin Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Human Insulin Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Human Insulin Drugs Revenue (US$, Mn), 2023-2030
Table 19. By Application - Global Human Insulin Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Human Insulin Drugs Sales (K Units), 2023-2030
Table 21. By Region ? Global Human Insulin Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Human Insulin Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Human Insulin Drugs Revenue (US$, Mn), 2023-2030
Table 24. By Region - Global Human Insulin Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Human Insulin Drugs Sales (K Units), 2023-2030
Table 26. By Country - North America Human Insulin Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Human Insulin Drugs Revenue, (US$, Mn), 2023-2030
Table 28. By Country - North America Human Insulin Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Human Insulin Drugs Sales, (K Units), 2023-2030
Table 30. By Country - Europe Human Insulin Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Human Insulin Drugs Revenue, (US$, Mn), 2023-2030
Table 32. By Country - Europe Human Insulin Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Human Insulin Drugs Sales, (K Units), 2023-2030
Table 34. By Region - Asia Human Insulin Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Human Insulin Drugs Revenue, (US$, Mn), 2023-2030
Table 36. By Region - Asia Human Insulin Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Human Insulin Drugs Sales, (K Units), 2023-2030
Table 38. By Country - South America Human Insulin Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Human Insulin Drugs Revenue, (US$, Mn), 2023-2030
Table 40. By Country - South America Human Insulin Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Human Insulin Drugs Sales, (K Units), 2023-2030
Table 42. By Country - Middle East & Africa Human Insulin Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Human Insulin Drugs Revenue, (US$, Mn), 2023-2030
Table 44. By Country - Middle East & Africa Human Insulin Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Human Insulin Drugs Sales, (K Units), 2023-2030
Table 46. Novo Nordisk Corporate Summary
Table 47. Novo Nordisk Human Insulin Drugs Product Offerings
Table 48. Novo Nordisk Human Insulin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Sanofi Corporate Summary
Table 50. Sanofi Human Insulin Drugs Product Offerings
Table 51. Sanofi Human Insulin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 52. Eli Lilly Corporate Summary
Table 53. Eli Lilly Human Insulin Drugs Product Offerings
Table 54. Eli Lilly Human Insulin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 55. Biocon Corporate Summary
Table 56. Biocon Human Insulin Drugs Product Offerings
Table 57. Biocon Human Insulin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer Human Insulin Drugs Product Offerings
Table 60. Pfizer Human Insulin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Wockhardt Corporate Summary
Table 62. Wockhardt Human Insulin Drugs Product Offerings
Table 63. Wockhardt Human Insulin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 64. Julphar Corporate Summary
Table 65. Julphar Human Insulin Drugs Product Offerings
Table 66. Julphar Human Insulin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 67. Exir Corporate Summary
Table 68. Exir Human Insulin Drugs Product Offerings
Table 69. Exir Human Insulin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 70. Sedico Corporate Summary
Table 71. Sedico Human Insulin Drugs Product Offerings
Table 72. Sedico Human Insulin Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Human Insulin Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2023 (K Units)
Table 74. Global Human Insulin Drugs Capacity Market Share of Key Manufacturers, 2020-2023
Table 75. Global Human Insulin Drugs Production by Region, 2018-2023 (K Units)
Table 76. Global Human Insulin Drugs Production by Region, 2023-2030 (K Units)
Table 77. Human Insulin Drugs Market Opportunities & Trends in Global Market
Table 78. Human Insulin Drugs Market Drivers in Global Market
Table 79. Human Insulin Drugs Market Restraints in Global Market
Table 80. Human Insulin Drugs Raw Materials
Table 81. Human Insulin Drugs Raw Materials Suppliers in Global Market
Table 82. Typical Human Insulin Drugs Downstream
Table 83. Human Insulin Drugs Downstream Clients in Global Market
Table 84. Human Insulin Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Insulin Drugs Segment by Type
Figure 2. Human Insulin Drugs Segment by Application
Figure 3. Global Human Insulin Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Insulin Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Human Insulin Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Human Insulin Drugs Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Insulin Drugs Revenue in 2022
Figure 9. By Type - Global Human Insulin Drugs Sales Market Share, 2018-2030
Figure 10. By Type - Global Human Insulin Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Human Insulin Drugs Price (US$/Unit), 2018-2030
Figure 12. By Application - Global Human Insulin Drugs Sales Market Share, 2018-2030
Figure 13. By Application - Global Human Insulin Drugs Revenue Market Share, 2018-2030
Figure 14. By Application - Global Human Insulin Drugs Price (US$/Unit), 2018-2030
Figure 15. By Region - Global Human Insulin Drugs Sales Market Share, 2018-2030
Figure 16. By Region - Global Human Insulin Drugs Revenue Market Share, 2018-2030
Figure 17. By Country - North America Human Insulin Drugs Revenue Market Share, 2018-2030
Figure 18. By Country - North America Human Insulin Drugs Sales Market Share, 2018-2030
Figure 19. US Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 20. Canada Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. Mexico Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. By Country - Europe Human Insulin Drugs Revenue Market Share, 2018-2030
Figure 23. By Country - Europe Human Insulin Drugs Sales Market Share, 2018-2030
Figure 24. Germany Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. France Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. U.K. Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. Italy Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 28. Russia Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Nordic Countries Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. Benelux Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. By Region - Asia Human Insulin Drugs Revenue Market Share, 2018-2030
Figure 32. By Region - Asia Human Insulin Drugs Sales Market Share, 2018-2030
Figure 33. China Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Japan Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. South Korea Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. Southeast Asia Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 37. India Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. By Country - South America Human Insulin Drugs Revenue Market Share, 2018-2030
Figure 39. By Country - South America Human Insulin Drugs Sales Market Share, 2018-2030
Figure 40. Brazil Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Argentina Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - Middle East & Africa Human Insulin Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - Middle East & Africa Human Insulin Drugs Sales Market Share, 2018-2030
Figure 44. Turkey Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Israel Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. Saudi Arabia Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 47. UAE Human Insulin Drugs Revenue, (US$, Mn), 2018-2030
Figure 48. Global Human Insulin Drugs Production Capacity (K Units), 2018-2030
Figure 49. The Percentage of Production Human Insulin Drugs by Region, 2022 VS 2030
Figure 50. Human Insulin Drugs Industry Value Chain
Figure 51. Marketing Channels
